Growing Need for Companion Diagnostics is Evident at Drug Discovery Event
The momentum for targeted therapies has downstream implications for clinical laboratories
The momentum for targeted therapies has downstream implications for clinical laboratories
From – Diagnostic Testing & Emerging Technologies
Summer may be over but the fight against the mosquito-borne virus, Zika, continues in earnest. Locally-mosquito-transmitted cases in…
From – Diagnostic Testing & Emerging Technologies
The U.S. Food and Drug Administration (FDA) recently approved the first rapid molecular test for detection of antibiotic resistance directly from…